1,089
Views
16
CrossRef citations to date
0
Altmetric
Note

Herquline A, produced by Penicillium herquei FKI-7215, exhibits anti-influenza virus properties

, , , , , , , , , & show all
Pages 59-62 | Received 15 Dec 2015, Accepted 15 Feb 2016, Published online: 21 Mar 2016

Figures & data

Fig. 1. Structure of herquline A (1).

Fig. 1. Structure of herquline A (1).

Table 1. Anti-influenza virus activity spectrum of 1.

Fig. 2. Inhibitory activity of 1 against influenza virus replication. Open column = control (4% CH3OH solution); closed column = 1 treatment groups; dotted column = ribavirin treatment groups. Statistical significance of differences between control and compound treatment groups was determined using two groups two-tailed Welch’s t-test. *, #, p < 0.0001 was taken as the level of statistical significance. Each column represents the mean ± SD (n = 6–9).

Fig. 2. Inhibitory activity of 1 against influenza virus replication. Open column = control (4% CH3OH solution); closed column = 1 treatment groups; dotted column = ribavirin treatment groups. Statistical significance of differences between control and compound treatment groups was determined using two groups two-tailed Welch’s t-test. *, #, p < 0.0001 was taken as the level of statistical significance. Each column represents the mean ± SD (n = 6–9).
Supplemental material

Supplemental_Section20160222_final.doc

Download MS Word (7.2 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.